Search results
Results from the WOW.Com Content Network
The company will need to demonstrate why its DNA based approach is “superior.” ... the average price target of $26.50 implies 31% upside from current levels. (See Inovio stock-price forecast ...
It has also raised its dividends for nine years in a row, which makes it one of the best dividend stocks on our list. The company currently offers $0.1525 per share in quarterly dividends, with a ...
This strong market position generates substantial cash flows that support shareholder returns. Turning to the specifics, the pharmaceutical giant offers investors a 4.3% dividend yield backed by a ...
This week, one of the key players in the COVID-19 vaccine race took a leap forward.On Tuesday, Inovio Pharmaceuticals (INO) announced that Thermo Fisher Scientific had signed a letter of intent to ...
Inovio Pharmaceuticals (NASDAQ:INO) is heating up, as investors continue to flock to certain stocks for the novel coronavirus. Shares of INO stock have rallied 140% from the April 15 low to the ...
[4] [23] Inovio has partnerships with manufacturers to scale up production of a vaccine if preliminary efficacy trials are successful. [18] In April 2020, the company began human Phase I safety studies of its lead vaccine (INO-4800) in the United States, and a Phase I-II trial in South Korea, to test for immunization against the COVID-19 virus.
The company offers a monthly dividend of $0.035 per share for a dividend yield of 13.04%, as recorded on December 5. Oxford Square Capital Corp. (NASDAQ:OXSQ) showed strong results in Q3 2022.
In this article, we discuss 10 best diversified dividend stocks to buy now. You can skip our detailed analysis of best dividend stocks and their returns over the years, and go directly to read 5 ...